Your 90-Day AR Analysis is complimentary - See your true collection gap.

Read our latest medical billing services and RCM related blogs

Is Your Orthopedic AR Ready to Close Out Before Year-End?

Is Your Orthopedic AR Ready to Close Out Before Year-End?

Probably not, and that’s normal. Most orthopedic groups and multi-surgeon facilities carry a meaningful chunk of orthopedic AR sitting past 90 and 120 days heading into Q4, largely because joint and spine procedures carry 90-day global billing periods, implant documentation delays, and workers’ comp cases that age slower than routine claims. The real question isn’t […]

Read More.. Is Your Orthopedic AR Ready to Close Out Before Year-End?

Is Graft Application Billing Keeping Up With the CTP Rule Change?

Is Graft Application Billing Keeping Up With the CTP Rule Change?

Graft application billing has not kept pace with the CTP rule change for most wound care groups, and the gap shows up as underpayment on every claim still coded and documented the old way. CMS restructured how cellular and tissue-based products (CTPs) are paid under the CY 2026 Physician Fee Schedule Final Rule, moving most […]

Read More.. Is Graft Application Billing Keeping Up With the CTP Rule Change?

Which New Procedures Are Covered Under the CY2026 ASC Payment Rule?

Which New Procedures Are Covered Under the CY2026 ASC Payment Rule

The CY2026 ASC Payment Rule adds 289 procedures to the ASC Covered Procedures List through revised coverage criteria, plus 271 additional codes carried over as CMS phases out the Inpatient Only List, bringing the total number of newly ASC-eligible procedures to more than 500. What Changed in the CY2026 ASC Payment Rule? CMS finalized the […]

Read More.. Which New Procedures Are Covered Under the CY2026 ASC Payment Rule?

Is Root Cause Denial Analysis Missing From Your RCM Strategy?

Is Root Cause Denial Analysis Missing From Your RCM Strategy?

Yes, for most healthcare organizations, Root Cause Denial Analysis is missing, and that gap is exactly why the same denials keep resurfacing month after month. It is the practice of tracing every denied claim back to the operational or clinical breakdown that caused it, rather than reworking the claim and moving on. Most facilities treat […]

Read More.. Is Root Cause Denial Analysis Missing From Your RCM Strategy?

Are Medical Necessity Denials Draining Your Facility’s Margin?

Are Medical Necessity Denials Draining Your Facility’s Margin?

Yes, for most multi-provider practices and facilities, medical necessity denials are one of the largest, most preventable sources of revenue leakage on the books. They happen when a payer decides that the documentation submitted doesn’t justify the service billed, even when the care itself was completely appropriate. The result is a stalled claim, a frustrated […]

Read More.. Are Medical Necessity Denials Draining Your Facility’s Margin?

In-House vs. Outsourced Family Practice Billing: A Real Cost-Benefit Breakdown

In-House vs. Outsourced Family Practice Billing A Real Cost-Benefit Breakdown

In-house family practice billing typically costs $66,000 to $75,000 per 12 months per biller once salary, benefits, and software are counted, but the real comparison isn’t cost alone: outsourced partners specialized in family practice typically capture Chronic Care Management, Annual Wellness Visit, and Transitional Care Management revenue that generalist in-house teams routinely leave unbilled, which […]

Read More.. In-House vs. Outsourced Family Practice Billing: A Real Cost-Benefit Breakdown

Is Reactive Claim Denial Management Costing You $5M a Year?

Is Reactive Claim Denial Management Costing You $5M a Year?

Yes, for a mid-size multi-site health system, reactive claim denial management can realistically cost $5 million or more a year once you add up unrecovered write-offs, rework labor, delayed cash flow, and the staff hours spent fighting the same denials over and over. Most facilities never see the full number because it’s scattered across a […]

Read More.. Is Reactive Claim Denial Management Costing You $5M a Year?

Is the Cataract Reimbursement Cut Silently Hurting Your ASC Margin?

Is the Cataract Reimbursement Cut Silently Hurting Your ASC Margin?

Yes, in most cases the 2026 cataract reimbursement changes are hurting ASC margin, even when the headline number looks like an increase. The Medicare facility rate for cataract surgery (CPT 66984) rose 3.4% for 2026, but the physician payment for the same procedure fell 11%, and a separate CMS policy quietly reduced indirect practice expense […]

Read More.. Is the Cataract Reimbursement Cut Silently Hurting Your ASC Margin?
888-357-3226